Scout | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

This grant opportunity aims to support the discovery and validation of new therapeutic targets to develop pain treatments that are effective and have minimal side effects and low risk of abuse. Research should focus on identifying targets in the nervous system, immune system, or other body tissues that can be used to create new pain medications. The grant encourages basic science studies to va…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Dates

Opportunity Released: January 7, 2022

Open for Submission: January 7, 2022

Submission Deadline: December 6, 2024

Application Window Closes: December 6, 2024

Keywords

pain therapeutics

novel therapeutic targets

peripheral nervous system

central nervous system

immune system

basic science discovery

pain treatment

translational research

chronic pain

acute pain

underrepresented populations

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers